foxo4 dri patent FOXO4-DRI Targeted Apoptosis of Senescent Cells
Description
Third-party lab testing and a Certificate of Analysis (COA) are non-negotiable
Important: GHK-Cu has not been approved by the FDA for general consumer use
GHK-Cu may prevent oxidative stress in skin by regulating copper and modulating genes. International Journal of Molecular Sciences , 2015
This suggests that CPP-CAND successfully inhibited the FOXO4-p53 interaction in the nucleus (Figure
& Laplante, M
